Complement and Cardiovascular Risk in Adolescents

NCT02821104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2021-06-11

Study results available
· View outcomes & findings →

Summary

This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.

Conditions

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02821104 on ClinicalTrials.gov